CVR 38968254Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)CharlottenlundFounded 25 Sep 2017
Gross profit
-3.1K
DKK, annual report 2025
Result
-3.1K
DKK, annual report 2025
Equity
25K
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Devopharma ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexHN HOLDING 2010 ApSCVR 33081189, 50% to under 66.7% of capital and votes, since 25 Sep 2017
Friendly Holding ApSCVR 38101137, 25% to under 33.3% of capital and votes, since 25 Sep 2017
and 2 moreHenrik Nakskovsince 25 Sep 2017
Søren Luplau-Paghsince 25 Sep 2017
CVR 3228943615% to under 20% of capital and votessince 15 Jan 2026
CVR 3308118950% to under 66.7% of capital and votessince 25 Sep 2017
CVR 3810113725% to under 33.3% of capital and votessince 25 Sep 2017
CVR 4619417910% to under 15% of capital and votessince 15 Jan 2026
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
20% to under 25% of capital and votes25 Sep 2017 to 16 Apr 2019
25% to under 33.3% of capital and votes16 Apr 2019 to 15 Jan 2026
2 Danish companies.
SubsidiaryCVR 39691825100% of capital and votes
SubsidiaryCVR 3896915366.7% to under 90% of capital and votes
Found by searching the CVR owner register (ejerregister) for Devopharma ApS as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
25 Sep 2017 to 4 Nov 2026.
25 Sep 2017 to 4 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | -3 | -3 | -3 | -3 | -3 |
| Operating profit | -3 | -3 | -3 | -3 | -3 |
| Result for the year | -3 | -3 | -3 | -3 | -3 |
| Equity | 38 | 34 | 31 | 28 | 25 |
| Total assets | 100 | 100 | 100 | 100 | 100 |
| Employees (average) | 0 | 0 | 0 | 0 | 0 |
| Credit metrics (Dandex calculations) | |||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 0note 1 | 0note 1 | 0note 1 | 0note 1 | 0note 1 |
| ROIC (afkast af investeret kapital) | -6.2%note 2 | -6.8%note 2 | -7.4%note 2 | -8.2%note 2 | -9.2%note 2 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 10 Jul 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 6 Jul 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 8 Jul 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 2 Jul 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 4 Jul 2022
1 registered in CVR.
P-number 1022879398Strandvejen 301, 2920 Charlottenlund
